Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | KIF11 | P52732 | 9/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11650778 | 0.98 | TAAR1 (0.45) | TAAR1KIF11KCNH2CYP3A4CYP2D6 | |
| Hydrochloric Acid SCHEMBL5370098 | 0.91 | TAAR1 (0.42) | TAAR1KIF11SIGMAR1 | |
| SCHEMBL6560515 | 0.87 | KIF11 (0.42) | TAAR1KIF11ESR1ESR2KCNN4 | |
| SCHEMBL9774435 | 0.83 | KIF11 (0.63) | TAAR1KIF11KCNH2CYP3A4CYP2D6 | |
| SCHEMBL9447607 | 0.83 | KIF11 (0.41) | TAAR1KIF11ESR1ESR2KCNN4 | |
| SCHEMBL25298896 | 0.83 | KIF11 (0.41) | TAAR1KIF11ESR1ESR2KCNN4 | |
| SCHEMBL5425018 | 0.82 | SIGMAR1 (0.41) | KIF11ESR1ESR2SIGMAR1 | |
| SCHEMBL27956680 | 0.82 | KIF11 (0.40) | TAAR1KIF11CYP2D6ESR1ESR2 | |
| SCHEMBL5180404 | 0.81 | SIGMAR1 (0.42) | KIF11KCNN4SIGMAR1 | |
| SCHEMBL27560936 | 0.80 | KIF11 (0.42) | KIF11ESR1ESR2KCNN4PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8426596-B2 | Process of producing bleach boosters | BASF AKTIENGESELLSCHAFT (DE) | 2013-04-23 | — | — | US | disclosed |
| US-8129531-B2 | Using an isoquinoline compound; alkylation of benzonitrile; reduction ofnitrile to an amine; cyclization | BASF AKTIENGESELLSCHAFT (DE) | 2012-03-06 | — | — | US | disclosed |
| US-20110319622-A1 | PROCESS OF PRODUCING BLEACH BOOSTERS | BASF SE (DE) | 2011-12-29 | — | — | US | disclosed |
| EP-1891192-B1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | PROCTER & GAMBLE (US) | 2009-12-16 | — | — | EP | disclosed |
| US-20090149366-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | MIRACLE GREGORY SCOT | 2009-06-11 | — | — | US | disclosed |
| US-7504371-B2 | Organic catalyst with enhanced enzyme compatibility | THE PROCTER & GAMBLE COMPANY (US) | 2009-03-17 | — | — | US | disclosed |
| US-20080214819-A1 | Process of Producing Bleach Boosters | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-04 | — | — | US | disclosed |
| EP-1896561-A2 | PROCESS OF PRODUCING BLEACH BOOSTERS | BASF SE (DE) | 2008-03-12 | — | — | EP | disclosed |
| EP-1891192-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | The Procter and Gamble Company (US) | 2008-02-27 | — | — | EP | disclosed |
| US-20070197421-A1 | Organic catalyst with enhanced enzyme compatibility | PROCTER & GAMBLE COMPANY, THE | 2007-08-23 | — | — | US | disclosed |
| WO-2007001261-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | THE PROCTER & GAMBLE COMPANY (US) | 2007-01-04 | — | — | WO | disclosed |
| WO-2006134144-A2 | PROCESS OF PRODUCING BLEACH BOOSTERS | BASF AKTIENGESELLSCHAFT (DE) | 2006-12-21 | — | — | WO | disclosed |
| US-20060287210-A1 | Organic catalyst with enhanced enzyme compatibility | PROCTER & GAMBLE COMPANY, THE | 2006-12-21 | — | — | US | disclosed |
| US-5886183-A | Naphthalenelactamimide fluorescence dyes | CIBA SPECIALTY CHEMICALS CORPORATOIN | 1999-03-23 | — | — | US | disclosed |
| EP-0769532-A1 | Naphtholactamimide fluorescent dyes | Ciba SC Holding AG (CH) | 1997-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214819-A1 | Process of Producing Bleach Boosters | SQLE, BCHE, CAT | TAAR1 3852/4885KIF11 3069/4885KCNH2 1834/4885 |
| US-20060287210-A1 | Organic catalyst with enhanced enzyme compatibility | AOX1, ACHE, MPO | TAAR1 3226/4885KIF11 3946/4885KCNH2 1367/4885 |
| US-20110319622-A1 | PROCESS OF PRODUCING BLEACH BOOSTERS | SQLE, BCHE, CAT | TAAR1 3852/4885KIF11 3069/4885KCNH2 1834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.